The function of the ␤-amyloid protein precursor (␤APP), a transmembrane molecule involved in Alzheimer pathologies, is poorly understood. We recently reported the presence of a fraction of ␤APP in cholesterol and sphingoglycolipid-enriched microdomains (CSEM), a caveolae-like compartment specialized in signal transduction. To investigate whether ␤APP actually interferes with cell signaling, we reexamined the interaction between ␤APP and G o GTPase. In strong contrast with results obtained with reconstituted phospholipid vesicles (Okamoto et al., 1995) , we find that incubating total neuronal membranes with 22C11, an antibody that recognizes an N-terminal ␤APP epitope, reduces high-affinity G o GTPase activity. This inhibition is specific of G ␣o and is reproduced, in the absence of 22C11, by the addition of the ␤APP C-terminal domain but not by two distinct mutated ␤APP C-terminal domains that do not bind G ␣o . This inhibition of G ␣o GTPase activity by either 22C11 or wild-type ␤APP cytoplasmic domain suggests that intracellular interactions between ␤APP and G ␣o could be regulated by extracellular signals. To verify whether this interaction is preserved in CSEM, we first used biochemical, immunocytochemical, and ultrastructural techniques to unambiguously confirm the colocalization of G ␣o and ␤APP in CSEM. We show that inhibition of basal G ␣o GTPase activity also occurs within CSEM and correlates with the coimmunoprecipitation of G ␣o and ␤APP. The regulation of G ␣o GTPase activity by ␤APP in a compartment specialized in signaling may have important consequences for our understanding of the physiopathological functions of ␤APP.
The ␤-amyloid protein precursor (␤APP), a transmembrane precursor with a single transmembrane domain, is normally cleaved in its extracellular domain to yield soluble APP (Selkoe, 1994) . In addition to this normal processing, ␤APP is a precursor for the production of the amyloid polypeptides (␤A4) found in senile plaques and associated with Alzheimer's disease. It has been proposed that ␤A4 peptides are primarily derived from the 695 amino acid (aa) neuronal ␤APP (LeBlanc et al., 1996; . However, the cellular compartment(s) in which this cleavage occurs, the enzymes involved and, more generally, the physiological f unctions of the precursor have not been clearly elucidated.
Several studies suggest that ␤APP signals via the membrane (Kang et al., 1987; Schubert et al., 1989; Koo et al., 1993; Allinquant et al., 1995) and, therefore, that its cytoplasmic domain associates with molecules specialized in signal transduction. Accordingly, a few cytosolic proteins that interact with ␤APP C-terminal domain have been identified (Nishimoto et al., 1993; Fiore et al., 1995; Chow et al., 1996; Guénette et al., 1996; Hardy, 1997; Yan et al., 1997; Z ambrano et al., 1997) .
Among the latter are heterotrimeric G o -proteins, as suggested by the following observations. First, G ␣o coimmunoprecipitates with ␤APP (Nishimoto et al., 1993) . Second, in reconstituted phospholipid vesicles containing G o and ␤APP, stimulation of ␤APP with a monoclonal antibody directed against its N-terminal domain increases the turnover of G o GTPase activity (Okamoto et al., 1995) . Third, a familial Alzheimer's disease-associated mutated form of ␤APP constitutively activates G o in reconstituted vesicles and, if expressed in several cell lines, induces apoptosis through a mechanism involving the G-protein ␤␥ complex (Giambarella et al., 1997) .
In this context, the presence of a fraction of ␤APP in membrane microdomains with physical-chemical properties identical to those of caveolae (Bouillot et al., 1996) is highly significant. Neuronal microdomains lack the scaffolding protein caveolin, which is the signature of caveolae in many cell types (Parton, 1996) , including astrocytes (Cameron et al., 1997) . However, like caveolae, these cholesterol and sphingolipid-enriched membranes (CSEM) represent a site of accumulation for several cell-surface receptors, glycosyl phosphatidylinositol (GPI)-linked glycoproteins, and signaling molecules (Parton, 1996; Simons and Ikonen, 1997; Wu et al., 1997) .
The presence of ␤APP CSEM has been disputed (Parkin et al., 1997) , but also confirmed, by three groups who reported that, within these domains, ␤APP colocalizes with ␣-secretase (Ikezu et al., 1998) and with ␤1-40 and ␤1-42 amyloid peptides (Lee et al., 1998; Simons et al., 1998) . It is very important to clarify this issue, which bears consequences for our understanding of ␤APP functions, and to verify whether ␤APP, within CSEM, interacts physiologically with signaling molecules. This is why we have further investigated the physiological interaction of ␤APP with heterotrimeric G-proteins. Using several immunocytochemical and biochemical protocols, we demonstrate that ␤APP and G ␣o are colocalized within C SEM from embryonic neurons in which they interact physiologically and physically.
MATERIALS AND METHODS

Immunoc ytochemistr y and immunoprecipitation
Polyclonal antibodies against G ␣o , G ␣i2 , ␤APP C -terminal domain, and F3/ F11 were kindly provided by Drs V. Homburger [C entre National de la Recherche Scientifique (C N RS), Montpellier, France], P. Frey (Sandoz, Berne, Switzerland), and G. Rougon (C N RS, Marseille, France), respectively. The 22C11 anti-␤APP monoclonal antibody was from Boehringer Mannheim, and the anti-myc antibody was obtained from Dr. J. Bishop (University of C alifornia, San Francisco, CA) (Evan et al., 1985) . The specificity of all antibodies was verified by Western blotting. C T-15 and D2-2 antibodies were obtained from Dr S. S. Sisodia (Johns Hopkins University, Baltimore, MD) (Sisodia et al., 1993; Slunt et al., 1994) ; they respectively recognize ␤APP and amyloid precursor-like protein 2 (APL P2) and allowed us to verif y by Western blotting that in the embryonic cultures or tissues [embryonic day 15-16 (E15-E16) plus 4 -5 d in vitro or E19 embryos] used in this study, the 22C11 antibody and the polyclonal antibody from Dr P. Frey specifically recognize ␤APP and not APL P2 (Fig. 1) .
Immunocytochemistry on primary corticostriatal rat cultures was performed as described previously (Allinquant et al., 1994) . For immunoprecipitation, 40 g of Triton X-100-insoluble membranes in 500 l GTPase buffer (see below) was adjusted to 100 M MgSO 4 , 100 nM GTP, and 150 mM NaC l, and the G ␣o antibody was added overnight at 4°C before solubilization by 2% n-octylglucoside for 1 hr at 4°C and centrifugation (14,000 ϫ g, 4°C, 15 min). The supernatants were mixed with protein A-Sepharose saturated with 2% bovine serum albumin in 20 mM H EPES and 150 mM NaC l, pH 7.5. After 3 hr at room temperature (RT), the beads were centrif uged, washed 5 times in 20 mM H EPES and 150 mM NaC l, pH 7.5, resuspended in 5% SDS -Laemmli buffer, boiled at 100°C for 10 min, and centrif uged at RT (14,000 ϫ g, 15 min). Proteins in the supernatants were separated by SDS-PAGE before Western blotting. In some experiments, we used the more stringent protocol described by Rousselet et al. (1988) .
For G ␣o purification on ␤APP C -terminal (␤APP-C ter) affinity columns, peptides f used with a myc-tag (see below) were incubated overnight at 4°C with an anti-myc monoclonal antibody protein A-Sepharose column. The beads were washed twice, incubated (4°C, 8 hr) with 30 g of f usion peptides in the presence of protease inhibitors (1 mM Pefablock, 1 M leupeptin, 1 M pepstatin, and 0.3 M aprotinin), washed twice again, and f urther incubated overnight at 4°C with 50 g of membranes solubilized in 2% n-octylglucoside, 100 M MgC l 2 , and protease inhibitors. After five washes in the same buffer, the proteins were eluted in 5% SDS -Laemmli buffer, and the presence of G ␣o was analyzed by Western blot.
Electron microscopy
C OS-7 cells were transfected with a caveolin expression plasmid as described by Joliot et al. (1997) and grown for 48 hr on golden grids coated with formvar. Alternatively, E16 rat embryonic cortex were dissociated, and the cells were cultured for 4 -5 d on grids precoated with formvar and fibronectin (10 g /ml). C ells were then treated according to Stoorvogel et al. (1996) , except that peroxidase-labeled cholera toxin B subunit (C TX) was used as a cross-linking agent. To this end, the cells were incubated (5-10 min, RT) with peroxidase-labeled C TX (8 g /ml in serum free medium), washed three times with serum free medium, and f urther incubated (30 min, 4°C) in freshly prepared 3-3Ј-diaminobenzidine (1.5 mg /ml in 20 mM H EPES, pH 7.0, 70 mM NaC l, 50 mM ascorbic acid, and 0.02% H 2 O2). After three rinses (10 min each, 4°C) in 80 mM PI PES buffer, pH 7.0, the cells were washed (30 min, 4°C) in extraction buffer (80 mM PI PES, pH 7.0, 1 mM EGTA, 0.5 mM MgC l 2 , 5 mM ascorbic acid, and 0.5% Triton X-100), rinsed several times in 80 mM PI PES, pH 7.0, fixed for 1 hr with 2% paraformaldehyde plus 0.2% glutaraldehyde in phosphate buffer, and finally washed in PBS, pH 7.4 (PBS).
For immunocytochemistry, cells treated and fixed as above were incubated with 50 mM ammonium chloride in PBS for 10 min, incubated overnight in blocking buffer (PBS plus 0.5% Triton X-100, 20 mM glycine, and 0.1% gelatin), and processed for immunogold labeling as described previously (Joliot et al., 1997) . Briefly, C OS-7 cells transfected with the caveolin plasmid were incubated with an anti-caveolin antibody (1:500; Transduction Laboratories, Lexington, K Y) subsequently detected with 10 nm of gold-labeled Protein A Gold (PAG10). For double labeling, ␤APP was decorated with the anti-␤APP C -terminal domain, PAG15 protein A was then inactivated with glutaraldehyde (Stoorvogel et al., 1996) , and a second incubation with anti-G ␣o and PAG10 was performed. The grids were finally post-fixed with glutaraldehyde, dehydrated in ethanol, and dried using a critical point-drying apparatus.
Preparation of crude membrane and CSEM
E19 rat cortex and striatum, freed of meninges, were homogenized using 10 strokes of Dounce homogenizer and three passages through a G26 needle in cold 0.25 M sucrose buffer A (10 mM Tris, pH 7.4, 100 M EDTA, and protease inhibitors). The homogenate was loaded on a 1.7 M sucrose cushion in buffer A and centrif uged (150,000 ϫ g, 40 min, 4°C) in a SW41 rotor (Beckman Instruments). The membrane suspension collected at the 1.7 M/0.25 M interface was loaded on a second 1.7 M sucrose step. After centrif ugation (150,000 ϫ g, 40 min, 4°C), the membranes floating over 1.7 M sucrose were collected and washed in 10 mM Tris and 100 M EDTA, pH 7.4. The pellet collected after centrif ugation (150,000 ϫ g, 30 min, 4°C) was resuspended in buffer A with or without 1% Triton X-100 (on ice) and centrif uged (150,000 ϫ g, 40 min, 4°C). The pellet was washed again and resuspended in GTPase buffer for GTPase activity test or in 20 mM H EPES and 150 mM NaC l, pH 7.4, for protein quantification and immunoprecipitation.
Three independent protocols were used to prepare caveolae-like microdomains Carbonate step gradients. C arbonate step gradients were performed according to Song et al. (1996) . In brief, E19 brain tissues were homogenized with a Dounce homogenizer in 500 mM sodium carbonate, pH 11.0, sonicated, made 45% in sucrose, and placed at the bottom of a 5-35% discontinuous sucrose gradient in 25 mM M ES, pH 6.5, and 0.15 M NaC l (M BS) containing 250 mM sodium carbonate. After centrif ugation in a Beckman SW41 rotor (150,000 ϫ g, 16 hr, 4°C), 1 ml fractions were collected, diluted in M BS, and centrif uged (150,000 ϫ g, 30 min, 4°C), and each pellet was resuspended in GTPase buffer or in 20 mM H EPES and 150 mM NaC l, pH 7.4. 6 E16 rat cortical neurons cultured for 5 d were loaded on 7% SDS-PAGE and immunoblotted using either 22C11 or C T15, two antibodies recognizing ␤APP or D2-2, an antibody specific to APL P2. The protein bands revealed with 22C11 and C T15 are very similar and differ from that reacting with D2-2.
OptiPrep preparation. Membranes isolated on a Percoll (Pharmacia) step gradient (Smart et al., 1995) were sonicated and loaded at the bottom of a linear 10 -20% OptiPrep (Nycomed Pharma, Oslo, Norway) gradient. After centrif ugation at 52,000 ϫ g for 90 min, 4°C (SW41 rotor, Beckman), the top five fractions (5 ml) were made 25% in OptiPrep (9 ml total), placed under 2 ml OptiPrep 5%, and centrif uged (52,000 ϫ g, 90 min, 4°C). The opaque band collected in the 5% OptiPrep fraction was diluted in M BS and centrif uged (150,000 ϫ g, 16 hr, 4°C), and the final pellet was resuspended in GTPase buffer or in 20 mM H EPES and 150 mM NaC l, pH 7.4.
Sucrose gradient containing Triton X-100. According to Sargiacomo et al. (1993) , tissues homogenized in M BS plus 1% Triton X-100 were adjusted to 40% sucrose, placed at the bottom of a continuous 5-30% sucrose gradient in M BS, and centrif uged (150,000 ϫ g, 16 hr, 4°C). One milliliter fractions were collected, diluted in M BS, and centrif uged. Each pellet was resuspended in GTPase buffer or in 20 mM H EPES and 150 mM NaC l, pH 7.4.
Preparation of intrac ytoplasmic ␤APP recombinant peptides
The HoxA5 sequence present in pTmHoxA5R (Chatelin et al., 1996) was deleted (SacI and BssH2) and replaced by a synthetic oligonucleotide coding for the P spacer sequence RQIKIWFQNRRMKWKK (Prochiantz, 1996; Derossi et al., 1998) . The sequence coding for ␤APP cytoplasmic domain (649 -695 aa) was added in 3Ј of the spacer using synthetic oligonucleotides. After transformation, the bacterial (DE3Lys S) pellets of 500 ml of culture, induced by isopropyl ␤-D-thiogalactoside for 3 hr, were resuspended in 20 mM H EPES, pH 7.9, 1 mM EDTA, 5 mM MgC l 2 , and 10 g /ml DNase, frozen and thawed three times in liquid nitrogen, and adjusted to 8 M urea. After centrif ugation (20,000 ϫ g, 4°C, 1 hr), the supernatants were dialyzed against 20 mM H EPES, pH 7.9, 1 mM EDTA, 5 mM MgC l 2 , and 0.25 M NaC l, and loaded onto heparinSepharose columns. The purity of the recombinant peptides eluted in 20 mM H EPES, 1 mM EDTA, and 1 M NaC l was verified by SDS-PAGE and found to be above 80%.
High-affinit y GTPase activity assay
GTPase assay was performed according to Charpentier et al. (1993) . Briefly, 2-5 g of membranes or microdomains were incubated for 30 min at 30°C in a total volume of 100 l containing 20 mM H EPES, pH 7.5, 0.1 mM EGTA, 0.5 mM adenyl-5Ј-yl ␤,␥-imidodiphosphate, 0.1 mM ATP, 3 mM creatine phosphate, 0.2 mg /ml creatine kinase, and protease inhibitors. The 22C11 ␤APP antibody was preincubated with the membranes 2 hr at 4°C or 1 hr at 37°C, and the reaction was started by adding GTP (100 nM or 20 M final concentration), 200,000 cpm of [␥ 32 P]GTP (Dupont N EN, Boston, M A), and MgSO 4 (10 M final concentration). Controls were incubated in the same conditions without 22C11. When indicated, 22C11 was preincubated (1 hr at RT) with its epitope (2 mM). The reaction was stopped with 400 l of cold charcoal (5% washed several times in 20 mM NaH 2 PO 4 , pH 2.0). The mixture was kept on ice for 2-3 min and centrif uged at 13,000 ϫ g for 10 min. Radioactivity in the supernatant was measured by scintillation counting. High-affinity GTPase activity was calculated by substracting the radioactivity released in the presence of 100 nM and 20 M GTP, and the results were expressed in femtomoles of inorganic phosphate released per milligram of protein per minute. When indicated, the membranes were first incubated for 1 hr at 37°C with 7 M recombinant peptides in 10 mM Tris, 100 M EDTA, 200 mM NaC l, and protease inhibitors, centrif uged, and resuspended in GTPase buffer. All results presented in this study correspond to highaffinity GTPase activity. All reagents used in the GTPase experiments are from Sigma (St. L ouis, MO) and Boehringer Mannheim.
A DP ribosylation
ADP ribosylation with pertussis toxin (P TX) or C3 (gift from Dr. P. Boquet, Institute National de la Santé et de la Recherche Médicale, Nice, France) was as described in Brabet et al. (1990) . Membranes (25-50 g) were incubated (1 hr, 37°C) in 100 l containing 70 mM Tris-HC l, pH 7.5, 25 mM dithiothreitol, 20% glycerol, 1 mM EDTA, 0.1 mM MgC l 2 , 1 mM ATP, 10 mM thymidine, 10 mM nicotinamide, 1 Ci [ 32 P]NAD, P TX (2.5 g /100 l) or C3 (the appropriate dilution of C3 was established for each batch of enzyme), and 0.5 M NAD. For [ 32 P]ADP ribosylation with C TX, membranes (25 g of protein) were incubated for 1 hr at 37°C with 2-3 Ci of [ 32 P]NAD (Dupont N EN) in 100 l containing 50 g of toxin, 100 mM phosphate buffer, pH 7.5, 1 mM ATP, 10 mM thymidine, 10 mM arginine, 100 M GTP, and 100 M MgC l 2 . The reaction was stopped with 400 l of cold stop buffer (10 mM Tris-HC l, pH 7.5, 100 M EDTA, and 200 M NAD), and the membranes were washed twice in the same buffer. ADP ribosylated samples were alkylated with N-ethylmaleimide before separation by SDS-PAGE and quantification by phosphoimaging (Fuji). All reagents were from Sigma and Boehringer Mannheim.
RESULTS G ␣o interacts physiologically with the C-terminal part of ␤APP
In a reconstituted system associating G o and ␤APP within phospholipid vesicles, the anti-␤APP 22C11 antibody, which binds to a specific epitope in the extracellular domain of the protein, upregulates G o GTPase activity (Okamoto et al., 1995) . To verify whether we could use the regulation of high-affinity GTPase activities to follow the interaction of ␤APP with G-proteins, we applied a similar protocol to membranes prepared from the cortex/striatum of E19 rat embryos (the source of biological material used thereafter). In strong contrast with the findings of Okamoto et al. (1995) , the addition of 22C11 on brain membranes decreased the high-affinity GTPase activity (Fig. 2 A) . This effect was lost after membrane solubilization (Fig. 2 A) , was dosedependent ( Fig. 2 B) , and was specific because it was blocked at all 22C11 concentrations in the presence of the peptidic epitope recognized by the antibody (Fig. 2 B) . One possible explanation for this difference between our results and those reported earlier is the presence in whole membranes of ␤APP and/or G ␣o molecular partners not present in the reconstituted system of Okamoto et al. (1995) .
To identify the G-protein(s) involved in the downregulation of GTPase activity by 22C11, we analyzed the effect of the antibody on the ADP ribosylation of G ␣o /G ␣i , G ␣s , and Rho by PTX, CTX, and C3, respectively (Gill and Merens, 1978; Li, 1992; Hauser et al., 1993) . 22C11 only interfered with the ADP ribosylating activity of PTX, suggesting a preferential interaction with G ␣o /G ␣i (Fig. 2C) . To investigate whether the C-terminal domain of ␤APP interacts with G ␣o /G ␣i and whether this interaction downregulates the high-affinity GTPase, we cloned the intracytoplasmic domain (␤APP 649 -695 aa) downstream of a myc-tag. We also cloned and produced two versions of the C-terminal domain in which the histidines doublet involved in G ␣o /␤APP interaction (Nishimoto et al., 1993) were replaced with a glycine-proline (GP) or a glycine-leucine (GL) doublet (Fig. 2 D) . The three recombinant polypeptides were attached to an anti-myc-protein A matrix, and neuronal extracts solubilized in 2% n-octylglucoside were loaded onto the column. Figure 2 E illustrates that G ␣o strongly binds to the wild-type C-terminal domain of ␤APP and that mutating the histidine doublet dramatically reduces this interaction. In contrast, G ␣i2 did not bind the C-terminal domain significantly. When wild-type and mutated domains were incubated with neuronal membranes, only the wild-type domain was able to reduce the high-affinity GTPase activity (Fig. 2 F) . The latter experiments strongly suggest that GTPase inhibition requires a specific recognition between G ␣o and the ␤APP C-terminal domain and raise the possibility that 22C11 modifies this interaction, resulting in a downregulation of G ␣o GTPase activity.
Colocalization of ␤APP and G ␣o in axonal microdomains
We have reported previously that ␤APP is distributed into two distinct pools. As illustrated in Figure 3A , a large pool can be visualized after permeabilization with Triton X-100, whereas, in the absence of detergent (Fig. 3B) , only a small amount of ␤APP can be decorated with the 22C11 antibody. The latter restricted pool is primarily axonal, with some staining of the cell body, and within membrane domains specialized in signal transduction and enriched in cholesterol and glycosphingolipids (Allinquant et al., 1994; Bouillot et al., 1996) . The restricted pool present at the cell surface, although it only corresponds to ϳ5% of total ␤APP, is physiologically important because it localizes near or at the cell surface (Allinquant et al., 1994) . Furthermore, all neosynthesized ␤APP transits through this pool before being redistributed in other compartments via transcytosis (Simons et al., 1995; Yamazaki et al., 1995; Tienari et al., 1996) . Figure 4 , A and AЈ, illustrates, in corticostriatal neurons from E15 or E16 rat embryos cultured for 4 -5 d and fixed with paraformaldehyde without detergent, the colocalization of ␤APP and the GPI-linked glycoprotein F3/ F11, taken as a CSEM marker (Bouillot et al., 1996) . Using the same procedure, we observed that ␤APP is often colocalized with G ␣o within short axonal segments (Fig. 4C-E) . These results strongly suggest that G ␣o and ␤APP are colocalized in axonal microdomains. This pattern of staining differs strikingly from that obtained with an anti-neural cell adhesion molecule (NCAM) antibody, which at this stage exclusively recognizes the non-GPI-linked NCAM isoforms. Indeed, as shown in Figure 4 , B and BЈ, NCAM is ubiquitously distributed on the membrane and, as opposed to F3/F11 or G ␣o , does not colocalize with ␤APP.
To verify the association of G ␣o and ␤APP in CSEM at the ultrastructural level, we adapted the technology recently developed by Stoorvogel et al. (1996) , which permits the visualization and immunolabeling of specific compartment on nonsectioned cells. The original technology, aimed at the identification of proteins enriched in endosomes, is based on the use of horseradish peroxydase (HRP)-transferrin. Here, because we wanted to verify the presence of ␤APP and G ␣o in CSEM, we have used HRP-CTX, which binds to GM1, a glycosphingolipid highly enriched in CSEM. HRP-CTX was internalized by live cells grown Figure 2 . ␤APP and G ␣o interaction in total neuronal membranes. A, 22C11-induced decrease in GTPase activity (lef t) is lost after membrane solubilization (right). B, GTPase inhibition by 22C11 is dose-dependent and is abolished after incubation with the 22C11 epitope. Control (CTRL) is without 22C11. C, 22C11 decreases ADP ribosylation by P TX but not by CTX and C3. The radiolabeled substrates of PTX and CTX run with electrophoretic mobilities of 39 -45 kDa and that of C3 with an electrophoretic mobility of 21 kDa (data not shown). D, Primary structures of the three recombinant peptides. In two constructions, the histidine doublet (HH ) present in the wildtype ␤APP cytoplasmic domain has been replaced by a GP or GL doublet. E, G ␣o and G ␣i2 are present in neuronal extracts ( N on electron microscopy grids, and DAB was added. DAB polymerization at the surface of membrane domains enriched in GM1 (CSEM) makes them electron dense and cross links their proteins, thus leading to their specific fixation. C ytosolic proteins can then be removed by detergent treatment (Triton X-100), and the grids can be processed for whole-mount immunogold labeling.
We validated the technology by demonstrating that it permits the selective fixation and visualization of caveolae in C OS-7 cells. Indeed, Figure 5A illustrates that a large number of structures preserved in this procedure can be labeled with an antibody directed against caveolin, a marker of caveolae in fibroblasts. Nonlabeled electron-dense material corresponds primarily to cytoskeleton (Stoorvogel et al., 1996) . The same technique applied to neurons (Fig. 5B) demonstrates the presence and, in several cases, the colocalization, of ␤APP and G ␣o in electron-dense structures. Based on 13 pictures similar to that in Figure 5B , we counted that, of 747 G ␣o beads, 15.7 Ϯ 2.3% (mean Ϯ SEM) colocalized with ␤APP. Interestingly, when the cells were incubated with both Triton X-100 and saponin, a detergent that complexes cholesterol and therefore disrupts C SEM, this percentage (11 pictures and 446 beads) was reduced to 6.9 Ϯ 0.8%, although for technical reasons, the detergents had to be added after DAB polymerization and thus presented a reduced efficiency. The percentage of ␤APP associated with G o within caveolae is also ϳ15%. Therefore, ␤APP and G o can be covisualized in caveolae-like vesicles at the ultrastuctural level. The percentage of ␤APP and G o not colocalized suggests the existence of GM1-enriched membranes primarily containing either ␤APP or G o and the possible association of G o and ␤APP to the cytoskeleton.
G ␣o and ␤APP interactions are preserved in CSEM
The presence of ␤APP and G ␣o proteins in microdomains illustrated in Figures 4 and 5 was f urther verified by cell fractionation using three different protocols for caveolae or microdomain purification: carbonate step-gradient (Fig. 6 A) (Song et al., 1996) , OptiPrep gradients (Fig. 6 B) (Smart et al., 1995) , and Tritonresistance plus sucrose gradient (Fig. 6C) (Bouillot et al., 1996) . Figure 6 demonstrates that (1) glycoprotein F3/ F11, ␤APP, and G ␣o colocalize in microdomains purified according to the three protocols, (2) a basal GTPase activity is present in the microdomains, (3) the intensity of the GTPase activity correlates with the amount of G ␣o (Fig. 6 A, C) , and (4) 22C11 antibody antagonizes this GTPase activity in the three preparations (Fig. 6 A-C) .
Microdomains isolated in the presence of the nonionic detergent Triton X-100 (Fig. 6C, fractions 3-8 ) contained Ͼ80% of total GTPase activity present in total insoluble Triton X-100 material. This confirms previous results (Allinquant et al., 1994) and justifies the use of the Triton-insoluble pellet from E19 cortex/striatum as an easy source of CSEM. Figure 7A demonstrates that the basal GTPase activity present in this Tritoninsoluble material is significantly inhibited by the addition of 22C11 and that this inhibition is antagonized by the 22C11 epitope and is thus specific.
To further identify the GTPase activity, we used mastoparan, a peptide that directly activates G ␣o (at low and high concentrations) and G ␣i (only at high concentrations) (Higashijima et al., 1988) . Figure 7B illustrates that basal high-affinity GTPase activity is stimulated by mastoparan and that inhibition by 22C11 is high even at low mastoparan concentrations. This experiment, added to the fact that G o GTPase turnover is 10 times that of G i (Neer et al., 1984) , is in agreement with an inhibition of G ␣o GTPase activity by 22C11 in CSEM. The latter proposed physiological interaction between the G ␣o and ␤APP correlates with a specific physical interaction in Triton X-100-insoluble membranes as shown by the coimmunoprecipitation of ␤APP with G ␣o , but not with G ␣i2 (Fig. 7C) , or with G ␣i 1 and G ␣i3 using an antibody that recognizes the three proteins (data not shown). This interaction is very strong because coimmunoprecipitation occurs not only in the conditions of the GTPase assay but also in highly stringent conditions developed for the immunoprecipitation of transmembrane proteins (Rousselet et al., 1988) .
Finally, we needed to verify that the decrease in GTPase activity could not be attributed to a specific degradation of G ␣o after a conformation change induced by 22C11. To this end, CSEM was incubated with or without 22C11 in the conditions used for the GTPase assay, and G ␣o was immunoprecipitated. Figure 7D illustrates for five different experiments that incubation with 22C11 does not modify the amount of G ␣o in the preparation nor that of ␤APP coimmunoprecipitated with G ␣o .
DISCUSSION
In this report, we demonstrate that ␤-APP and G ␣o colocalize in neuronal CSEM and interact physically and physiologically in both total membranes and CSEM. Physical interactions are demonstrated by the coimmunoprecipitation of ␤APP with G ␣o and by the direct binding of G ␣o on a ␤APP C-terminal domain affinity column. The latter binding is specific because it is abol- Figure 3 . ␤APP is distributed in two pools. E15 neurons were fixed with 4% paraformaldehyde and processed for ␤APP immunolocalization using the 22C11 antibody. A, Permeabilization with Triton X-100 demonstrates the presence of ␤APP in all cell compartments. B, In the absence of Triton X-100, only short neurite segments are labeled (Allinquant et al., 1994) . Scale bar, 5 m.
ished by mutating a histidine doublet critical for ␤APP/G ␣o interaction (Nishimoto et al., 1993) . The physiological interaction is demonstrated by the downregulation of G ␣o GTPase activity after either addition of 22C11, a monoclonal antibody directed against a N-terminal epitope of ␤APP, or by that of the wild-type ␤APP cytoplasmic domain. We propose that (1) ␤APP interacts directly with G ␣o , (2) in total membranes and C SEM, the binding of ␤APP to G ␣o inhibits the basal G ␣o GTPase activity, and (3) extracellular signals, here mimicked by 22C11, can regulate this interaction. The fact that this interaction also occurs within a compartment specialized in signal transduction raises the possibility that one of the physiological functions of ␤APP is to regulate signal transduction.
The addition of 22C11 downregulates GTPase basal activity. This downregulation is dose-dependent and antagonized by the 22C11 epitope. Although we do not exclude that several GTPases could interact with ␤APP, the evidence for a ␤APP/G ␣o interaction is strong. First, the incubation with 22C11 partially inhibits the ADP ribosylation by P TX, demonstrating interaction of ␤APP with G ␣o and /or G ␣i . The absence of effect on the level of ADP ribosylation by C TX or C3 eliminates an implication of G s and Rho. Second, the amphiphilic peptide mastoparan is a well known activator of G ␣o and G ␣i GTPase activity. However, the levels of mastoparan required for the activation of the two GTPases are very different, and below 10 M, mastoparan preferentially activates G ␣o . The fact that 22C11 inhibits the GTPase activity induced at low mastoparan concentrations demonstrates that G ␣o is the 22C11 target. Third, G ␣o , but not G ␣i2 , binds to the ␤APP cytoplasmic domain, and this binding is lost if two histidines necessary for the latter binding are mutated. Accordingly, the inhibition of basal GTPase activity by the ␤APP cytoplasmic domain requires that this histidine doublet be present. Finally, ␤APP coimmunoprecipitates with G ␣o but not with G ␣i2 . The identification of G ␣o as the 22C11 target allowed us to verify that the addition of 22C11 does not provoke its specific degradation.
An interaction between ␤APP and G ␣o has already been reported by Okamoto and colleagues (1995) , who demonstrated that in a reconstituted system associating phospholipids and purified G o and ␤APP, the addition of 22C11 stimulates G o GTPase activity. In embryonic neuronal membranes and CSEM, our own observations confirm that 22C11 modulates an interaction between G ␣o and ␤APP. However, in strong contrast with the results of Okamoto and colleagues (1995) , we find that the addition of 22C11 downregulates G o GTPase activity. The striking difference between the two set of data are probably attributable to the presence, in the brain membranes, of molecules that interact with ␤APP and/or G o and are absent in the reconstituted system developed by Okamoto and colleagues (1995) . In fact, although G o GTPase stimulation is the general rule, downregulations have also been reported, which can imply an interaction of a cytosolic protein with the ␤␥ subunits (Schröder and Lohse, 1996) or a classical stimulation of G-protein-coupled receptors (Giguère et al., 1996; Ueda et al., 1996) . The fact that the same downregulation is observed in the absence of 22C11 when the ␤APP cytoplasmic domain is added to the preparation raises the possibility that, in our conditions, 22C11 acts by inducing a conformational change of the C-terminal domain or by freeing it from previous interactions.
In this study, we have followed the approach of Okamoto et al. (1995) , and we have used 22C11 as a mean to stimulate ␤APP. This does not give any clue on the natural ␤APP ligands, if any. Several nonmutually exclusive possibilities exist. First, ␤APP might interact with matrix components Mattson et al., 1993; Lee et al., 1995; Williamson et al., 1996) or with a real ligand as yet unidentified and may directly transduce a signal by recruiting trimeric G-proteins and/or other signaling partners. Second, ␤APP could interact in cis with other receptors or adhesion molecules and could regulate their signaling activity by interacting with cytoplasmic proteins, in particular G ␣o . The possibility for a molecule with a single transmembrane domain to interact with a receptor coupled to a G-protein has been demonstrated in the case of the epidermal growth factor receptor, which signaling through a heterotrimeric G-protein can involve G-coupled receptors such as endothelin-1, lisophosphatidic acid, and thrombin receptors (Daub et al., 1996) or the muscarinic m1 receptor (Tsai et al., 1997) . Similar interactions have been reported between PDGF and angiotensin II receptors (Linseman et al., 1995) .
Many data presented here are centered on a subcellular compartment with specific biochemical and biophysical properties and specialized in cell signaling as illustrated by its content in several kinases and G-proteins (Olive et al., 1995; Li et al., 1996; Solomon et al., 1996; Song et al., 1996; Wu et al., 1997) . They establish without ambiguity that ␤APP and G ␣o are present in Figure 5 . Colocalization of ␤APP and G ␣o in C TX-HRP stabilized structures. Cells were incubated with C TX-HRP and processed for transmission electron microscopy as indicated in Material and Methods. A, Caveolin expressed in C OS-7 cells by transfection is associated with CTX-HRP crossed-linked structures (arrowheads, 10 nm beads). B, Examples of the intracellular neuronal colocalization of ␤APP (15 nm beads) and G ␣o (10 nm beads) in HRP crossed-linked structures are indicated by arrowheads. Scale bars, 100 nm. this compartment. Indeed, this presence was observed using three different fractionation protocols, by immunocytochemistry in the absence of detergent, and by a whole immunoelectron microscopy technology allowing the specific preservation of GM1-enriched microdomains. In earlier reports (Allinquant et al., 1994; Bouillot et al., 1996) , we have quantified the percentage of ␤APP in the Triton-insoluble fraction and found that it corresponded only to 5% of total ␤APP expressed in the cells. Thus, according to the gradient in Figure 5 , ␤APP in C SEM only represents 4 -5% of total ␤APP. This percentage, although small, is functionally highly significant for the following reasons. First, what is most important in a signaling molecule is the percentage of protein accessible to the extracellular space. Although the amount of ␤APP visualized in the absence of permeabilization and colocalized at the cell surface with G ␣o is small, it is the only one in position to signal with molecules present in the extracellular space. Second, recent reports (Simons et al., 1995; Yamazaki et al., 1995; Tienari et al., 1996) strongly suggest that most neosynthesized ␤APP is first sent to the axon and then endocytosed and transported retro- Figure 6 . GTPase activity present in caveolar microdomains, isolated according to three different protocols, is decreased by 22C11. The presence of F3, ␤APP, and G ␣o was observed in the high-speed pellets of microdomains isolated by carbonate step ( A), OptiPrep ( B) , and sucrose gradient in the presence of Triton X-100 (C, f ractions 3-8). In the three types of preparation, the high-affinity GTPase activity present in microdomains was decreased by 22C11 (although the percentage of inhibition can vary between preparations). Note that the second step in the OptiPrep protocol ( B) corresponds to the concentration within one fraction of cholesterol-rich membranes; *p Ͻ 0.01. In C, the GTPase activity in fractions 9 -12 corresponds to the presence of G o in the latter fractions (data not shown), although this does not appear with the revelation time selected here. gradely into the dendrites. The mechanism for axonal addressing involves the binding of the intramembranous domain of ␤APP to the sphingolipid GM1 . Because in the anterograde pathway GM1 is primarily present in caveolae and CSEM (Parton, 1996) , it is likely that, even if at a given time microdomains only contain 5% of total ␤APP, a much higher percentage of ␤APP transits through C SEM before redistribution into the entire neuron.
Dysregulation of G ␣o activity by ␤APP may have important consequences through its downstream effects on the signaling activity of several receptors. In this context, it is interesting that Alzheimer's disease might be associated with signaling defaults. Particularly striking examples of the latter association are (1) the impaired learning and long-term potentiation observed in transgenic mice overexpressing the C -terminal domain of ␤APP (Naibantoglu et al., 1997) , and (2) the abnormal amounts of free ␤␥ subunits, which initiate apoptosis and DNA fragmentation in the case of ␤APP mutations found in familial cases (Yamatsuji et al., 1996; Giambarella et al., 1997) . Reciprocally, mediators that modulate the intracellular GTPase activity can interfere with the maturation or degradation of ␤APP, as observed for some muscarinic or glutamatergic receptors (Nitsch et al., 1992; Lee et al., 1995; Slack et al., 1995) . Finally and most importantly, interactions with G o or other molecular targets within microdomains could regulate ␤APP processing and the production of secreted ␤APP and of the amyloidogenic fragments (Ikezu et al., 1998; Lee et al., 1998) . Figure 7 . The GTPase activity present in Triton X-100-resistant membranes decreased by 22C11 primarily corresponds to G ␣o . A, The decrease in GTPase activity (*p Ͻ 0.005) induced by 22C11 is antagonized by the 22C11 epitope. B, Basal GTPase activity is stimulated by mastoparan, and the stimulation is dose-dependent. Inhibition by 22C11 is similar (ϳ70%) in the absence of mastoparan and at all mastoparan concentrations used in this experiment. C, ␤APP is coimmunoprecipitated with G ␣o . No ␤APP immunoprecipitation is observed in the absence of antibody (Ϫ) or with an anti-G ␣i2 antibody (ϩ). D, Membranes from five independent experiments incubated with (ϩ) or without (Ϫ) 22C11 in the conditions of the GTPase assay were immunoprecipitated with the anti-G ␣o antibody. The immunoprecipitates were run on a gel, and both G ␣o and coimmunoprecipitated ␤APP were revealed with the appropriate antibodies.
